StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3056% above fair value
$30.00−0.67 (-2.18%)

Close on Nov 3, 2026Market cap $170.99BP/E 42.9Yield 5.73%

Pfizer BeneFIX [legacy through FY24] by Year

BeneFIX (coagulation factor IX) [legacy through FY24] — Worldwide operational (constant-currency) YoY (%) (%)

Pfizer BeneFIX [legacy through FY24]: -8.0% in FY2024, up 10.0 pts from a year earlier. That is the highest of the 8 years on record here. No newer figure appears in the documents we track.

Latest, FY2024
-8.0%
Period ended Dec 31, 2024
Change on a year earlier
+10.0 pts
-18.0% in FY2023
History
8 years
Since FY2017
Sources
8
Documents cited below

Where the FY2024 figure comes from

“|| BeneFIX | 381 | 424 | (10%) | (8%) | 200 | 225 | (11%) | 181 | 200 | (9%) | (5%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Pfizer BeneFIX [legacy through FY24] (%), annual FY2017–FY2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/benefix-leg-oper-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?